Functional realization of many signalling proteins and transcription factors implicated in the development
Introduction. Multiple sclerosis (MS) is the most common, extremely heterogeneous clinically, chronic inflammatory disease of the CNS affecting about 2.5 million people around the world (2500 of them in Latvia), presumably young adults, with onset usually at the second to fourth decade of life and, similarly to other autoimmune diseases, women being affected 3-4 times more frequent than men [1] .
About 90 % of MS patients experience the relapsingremitting MS course (RRMS), the majority of these patients enter a secondary progressive course (SPMS) and about 10 % of MS patients show a primary progressive MS form, characterized by the progression of neurological disability from onset [2] . The cause of MS is not clear. The disease develops in genetically susceptible individuals with contributions of environmental factors, such as infection, sunlight exposure, vitamin D deficiency [3, 4] . The MS susceptible loci had been identified in the regions containing genes with immune, co-stimulatory, signal transduction functions and related to vitamin D function [5] [6] [7] [8] [9] [10] .
Ubiquitin proteasome system (UPS) plays a crucial role in immunity and its disregulation and/or modulation may influence the MS development and progression. The 20S proteasome had been identified as a target of the humoral autoreactive immune response [11] and a major autoantigen in MS patients [12] . The proteolytic activities of proteasomes are reduced in brain tissue of MS patients [13] . The inhibition of proteasomes and lysosomal proteases involved in major histocompability complex II antigen presentation was shown to improve the MS therapeutic effect [11, 14] .
Modulation of UPS efficiency could be influenced by polymorphisms in the genes encoding UPS related proteins. The immunoproteasome PSMB9 codon 60HH variant was observed to have a reduced risk of developing MS in HLA-A*02 + Italian females [15] .
Coexistence of autoimmune diseases recently evaluated statistically [16] suggests a possibility of their common origin. In fact, despite generally heterogeneous genetic architecture of the particular disease, some polymorphic loci were shown to be shared by MS and other autoimmune diseases including rheumatoid arthritis [6, 17, 18] and type 1 diabetes mellitus [19, 20] .
Genetic variations in the 14q11-24 genes encoding proteasomal subunits were implicated previously in susceptibility to autoimmunity, type 2 diabetes mellitus, cardio-vascular disorders, and population adaptation to environment [21, 22] . It appears that there is a large potential for some of these mutations also to be associated with multiple sclerosis.
The aim of the current study was to genotype the rs11543947 and rs2348071 polymorphisms of the PSMB5 and PSMA3 genes encoding proteasomal proteins on the MS main, subtype and sex specific association in Latvian population.
Materials and methods. Case-control study. The case group consisted of 281 MS patients referred to the Latvian Maritime Medicine Center, Vecmilgravis Hospital. MS patients were diagnosed according to the revised 2010 McDonald criteria [23] and assigned to the RRMS (188 patients) and SPMS (93 patients) groups. Detailed description of the subject groups is given in Table 1 . Total control group of 305 samples were represented by the two independent sample sets including the previously characterized [21, 22] first Latvian population study consisting of 191 samples and the second Latvian population study of 114 newly collected samples. Ethnic origin of the subjects was not recorded; all of them represent very mixed inhabitants of Riga, forming some «average» genotype for North-East Europe. The data on the rs11543947 and rs2348071 allele and genotype frequencies in the first Latvian population sample set were extracted from [21, 22] to be compared with the data on genetic diversity obtained for the second Latvian population study and then to be grouped providing a total control group of 305 healthy individuals. All controls were carefully assessed to exclude the diagnosis of any inflammatory disorders. The studies were approved by the Central Medical Ethics Commission of the Republic of Latvia Ministry of Health and informed consent was obtained from all the studies participants.
DNA extraction and genotyping. Genomic DNA was extracted from nucleated blood cells using a kit for the genomic DNA extraction («Fermentas», Lithuania) and from oral swabs using the salting out method [24] . The rs11543947 and rs2348071 genotyping technologies were the same as published previously [21, 22] including primer sequences, basic PCR procedure and analyses of amplified and digested products. For quality control, the 16 randomly chosen samples per each marker were genotyped in duplicate in different experiments. The concordance of genotyping was 100 %. The genotyping data were verified by direct sequencing of the corresponding DNA fragments in both directions Data analysis. Single locus genotypes and alleles' frequencies were estimated by direct gene counting. The deviation from the Hardy-Weinberg equilibrium (HWE) and differences between case and control groups in allele, genotype and haplotype frequencies were evaluated by c 2 using XLSTAT 2013 software for Windows. The dominant, recessive, over dominant and multiplicative genetic models for every individual locus were designed according to [25] and analysed by using 2´2 contingency tables. The odds ratio (OR) more than 2 and less than 0.5 was considered to be clinically significant. Stratification was performed by MS courses and sex.
Results and discussion. In both MS and the two Latvian population cohorts, the genotyping call rate was 100 %. Both markers were found to be in HWE in controls (c 2 = 2.72; p > 0.05). Allele and genotype spectrums and distributions were found to be similar (P > 0.05) for the first (191 samples, [21, 22] ) and the second (114 newly collected samples) Latvian population studies for each marker. The data of both population studies were grouped and total control group of 305 samples was used for further analysis. In cases the genotype distribution corresponded to HWE (c 2 = 2.72; P > 0.05) for rs11543947, however a strong deviation from HWE was observed for rs2348071 (c 2 = 14.14; P < 0.01). Figure illustrates SNPs the genetic diversity in cases and controls.
Depending on the transcript variant, the rs11543947 locus belongs to the PSMB5 gene exon 1 (c. 70 C > T) or intron 1 (c. 112 + 300 C > T). The allele and genotype frequencies of this SNP were found to be similar for cases and controls, RRMS and SPMS cohorts (Figure, A) as well as for sexes (not shown). Similarly to current data, in Latvians this SNP did not show any association with juvenile idiopathic arthritis [22] and bronchial asthma in children (own unpublished data). However, this locus appears to be susceptible to familial obesity in Latvian children (own unpublished data).
The rs2348071 SNP is located in the intron 7 of the PSMA3 gene (c. 543 + 138 G > A or c. 522 + 138 G > A depending on the transcript variant) and strongly discriminates Asians having as major an ancestral allele A (about 70 %) and other ethnics having as major an allele G (about 70 %). Transition A ® G happened in Caucasians about 15,000 years ago and was supported by positive selection in Caucasians over the world [21] . The allele frequencies observed in current study were similar for MS patients and controls, however genotype distribution was found to be significantly different (Figure, B) . Both common and rare allele homozygotes appear to be MS protective, however, heterozygous GA genotype showed strong (p < 0.001) MS main effect, and strong and moderate association with the SPMS and RRMS respectively (Table 2) .
Previously we have shown [21, 22] that nucleotide substitution at the rs2348071 may significantly change patterns of local targets for many regulatory molecules including proteins of CART, MEF2 and HBPX families known to mediate transcriptional control of neuronal differentiation and nucleo-and cytoplasmic ribonucleoprotein hnRNP A1 implicated in pathogenesis of many neurodegenerative diseases including multiple sclerosis [26] [27] [28] . Multiple sclerosis patients were shown to generate antibodies to hnRNP A1 [26] . This splicing signal affecting splicing and post-transcriptional modifi- Allele and genotype presentation in MS patients and controls: Ars11543947; B -rs2348071; (1 -control; 2 -MS (multiple sclerosis); 3, 4 -RRMS and SPMS (relapsing remitting and secondary progressive MS course respectively)) cation of majority of expressed genes in mammals, was shown to interact directly with PSMA3 proteins [29] and may be potentially involved in regulation of the PSMA3 gene expression through the rs2348071 allelespecific targeting. In our previous studies, the rs2348071 heterozygotes were identified also as risk factor in Latvians for juvenile idiopathic arthritis [22] , obesity in children with family history [30] and children bronchial asthma (own unpublished observation). In this study we have tried to analyse separately the groups of RRMS and SPMS patients, although the latter is considered to be the result of progression of the former. It should be mentioned that in some studies [31] the two forms appear to differ genetically. This provided background for the design of the study; in fact in our case the rs2348071 heterozygote genotype was stronger associated with SPMS than with RRMS (Table 2) . We suggest that the rs2348071 heterozygote genotype is a case of heterozygote disadvantage resulted from the imbalance of the locus functional capacity affecting human health possibly through the modulation and/or deregulation of the PSMA3 gene expression, UPS functionality and network of different genes and proteins involved in pathogenesis of multiple sclerosis and other neurodegenerative and autoimmune diseases.
Conclusions. Our results suggest susceptibility of the rs2348071 heterozygous genotype to multiple sclerosis in Latvians.
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